ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GDR Genedrive Plc

2.40
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.40 2.30 2.50 2.40 2.40 2.40 14,156 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -2.53 13.04M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 2.40p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 11.85p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £13.04 million. Genedrive has a price to earnings ratio (PE ratio) of -2.53.

Genedrive Share Discussion Threads

Showing 33376 to 33391 of 33475 messages
Chat Pages: 1339  1338  1337  1336  1335  1334  1333  1332  1331  1330  1329  1328  Older
DateSubjectAuthorDiscuss
13/11/2024
08:45
More importantly, it's up on much higher volume.Bodes very well.
premium beeks
13/11/2024
08:45
SEA about to fly
smraynot
13/11/2024
08:44
Buckle up bulls
atmysignal
13/11/2024
08:41
High tight flag?
hazl
13/11/2024
08:38
I expect it will be in play most of the day.

IMO

hazl
13/11/2024
08:32
'Why do we need to use Genedrive?

Babies admitted to the TMBU often need antibiotics. One antibiotic we use is called Gentamicin, which is a drug belonging to a family of antibiotics called Aminoglycosides.

Gentamicin can sometimes lead to kidney or hearing problems, but side-effects are relatively uncommon, so Gentamicin has remained one of our first-choice antibiotics because it works well and has low antibiotic resistance.

Low antibiotic resistance means that germs are less likely to build up a resistance to antibiotics in the future.

However, one in 500 people have a genetic variation (a difference in their DNA) that can put them at higher risk of side effects from Gentamicin. For people who have this genetic variation, even a single dose can sometimes cause severe hearing loss that cannot be cured.'

Same source as above.

hazl
13/11/2024
08:26
POLX Polarean Imaging about to break out above 2p soon. Mcap is peanuts and cash position is much longer to Q2 2026 and revenue are higher and growing even more quickly than this.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 155p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations.

Putting this UK recovery play potential on radars.

1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M.

APPROX 13P SHARE PRICE EQUIVALENT FOR POLX


2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M

APPROX 48P SHARE PRICE EQUIVALENT FOR POLX


3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million.

APPROX 22P SHARE PRICE EQUIVALENT FOR POLX

4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout

POLX easy buyout target more massive premiums as per the above imv. DYOR, not advice.

m_night10
13/11/2024
08:18
And batiatus quiet is the biggest bonus lolm
bones698
13/11/2024
08:06
2.5 and really going!!!!
billthebank
13/11/2024
07:47
Genedrive a company that's actually good for society.

Caught the Government's attention too.

hazl
13/11/2024
06:33
Now that we are included in the Government's list and are being used in NHS locations, we are having our validity heralded.
This has been endorsed at the top for success, it seems.
Let's hope we are not taken out too cheaply before then!


*Genedrive featured in UK Department for Business & Trade's genomics spotlight'.

hazl
12/11/2024
23:38
Your flogging a dead horse now batiatus . Enjoy watching the rise tomorrow and we will enjoy the silence again . Idiot
bones698
12/11/2024
22:31
One thing for sure is that the share price has been on a downtrend. From £2 to 5p, and from 5p to now 2p.

The companies fundamentals have not changed one bit. Monthly cash burn is still £400-600K. There have been no other sales besides the £100K 9 months ago.

The directors cannot expect to sit around all day taking a salary without providing any value to shareholders.

They need to prove the kits can sell and start making some profit.

As things stand, it's just a weeks after weeks without sales, only cash burn.

The only thing that is coming is a fundraise.

(G)enuinely (D)on't (R)ecommend

batiatus
12/11/2024
20:24
You obviously didn't watch the rise upto 5p . Another Muppet
bones698
12/11/2024
19:59
Up one day down the next
muttznutz1953
12/11/2024
19:56
What do you call small batty, apart from your tiny brain of courseWe've had 40% swings here for weeks, what more do you want?What a foreskin.
premium beeks
Chat Pages: 1339  1338  1337  1336  1335  1334  1333  1332  1331  1330  1329  1328  Older

Your Recent History

Delayed Upgrade Clock